NLS Pharmaceutics

NCEL

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-39.8M

EBITDA$-37.87M

EBIT$-37.91M

Pre-tax Income$-8.76M

Net Income$-38.5M

Net Cash$0

Cash Equivalent$917.15K

Total Debt$1.27M

Net Debt$1.27M

Book Value$-6.27M

Book Value Per Share-6.85

Return on Equity (ROE)-140.85%

Return on Assets (ROA)-88.70%

Return on Invested Capital (ROI)-140.85%

Net Profit Marginundefined

Current Ratio2.69

Quick Ratio2.56

Long-Term Debt / Equity0.00